Use of Glucagon-Like Peptide-1 Agonists Among Individuals Undergoing Bariatric Surgery in the US
About this episode
This episode features an interview with experts discussing the use of GLP-1 agonists in bariatric surgery patients in the US.
Interview with G. Caleb Alexander, MD, MS, and Hemalkumar B. Mehta, MS, PhD, authors of Use of Glucagon-Like Peptide-1 Agonists Among Individuals Undergoing Bariatric Surgery in the US. Hosted by Jamie Coleman, MD. Related Content: Use of Glucagon-Like Peptide-1 Agonists Among Individuals Undergoing Bariatric Surgery in the US The GLP-1 Era—What Comes After Bariatric Surgery?
More episodes of JAMA Surgery Author Interviews
- Small Bites vs Large Bites for Closure of Abdominal Midline Incisions
- Oncologic Risk of Missed Appendiceal Tumors in Acute Appendicitis
- Contemporary Outcomes of Cholecystectomy
- Data and the Art of Surgical Preference Card Maintenance
- Mortality Among Surgeons in the United States
- Diagnosis and Management of Hemodialysis Access Complications
Explore listener stats, chart rankings, contacts and more on the JAMA Surgery Author Interviews podcast page.